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We report meningitis with diffuse neuralgic pain or 
polyradiculoneuropathy associated with PCR-documented 
acute hepatitis E in 2 adults. These observations suggest 
that diagnostic testing for hepatitis E virus should be 
conducted for patients who have neurologic symptoms and 
liver cytolysis.
Hepatitis E virus (HEV), a major cause of acute hepatitis in tropical and subtropical countries, is 
emerging in industrialized countries, where an increasing 
number of autochthonous hepatitis E cases have been 
reported (1–5). Nonetheless, the clinical spectrum of HEV 
infection still might be incompletely characterized. During 
the past decade, 12 cases of hepatitis E with neurologic 
signs and symptoms have been reported (1–4,6–13). We 
report 2 cases of meningitis or polyradiculoneuropathy 
in association with PCR-documented acute hepatitis E in 
France during 2010.
The Cases
Case 1 occurred in a 54-year-old woman hospitalized 
in August 2010 for subacute diffuse paresthesia and 
pain of the limbs (with ulnar localization on upper limbs 
and proximal pain in legs), headaches, cervicalgia, 
photophonophobia, transient fever, and nausea. Refl exes 
were all present, without pyramidal signs. No abnormalities 
were found by medullar magnetic resonance imaging. 
Nerve conduction study was not done because of rapid 
clinical improvement beginning <1 week after onset. The 
patient had no notable medical history. At admission, 
alanine aminotransferase level was 566 IU/L (reference 
values 8–34 IU/L), γ-glutamyl transferase level was 184 
IU/L (reference 9–38 IU/L), alkaline phosphatase level 
was 125 IU/L (reference 42–98 IU/L), and bilirubin was 
11 μmol/L (reference 5–34 μmol/L). Cerebrospinal fl uid 
(CSF) was clear; protein and glucose levels were 1.03 g/L 
(reference 0.15–0.45) and 3.4 mmol/L (reference 3.0–4.5 
mmol/L), respectively; leukocyte count was 74 cells/mm3, 
including 90% mononuclear cells; erythrocyte count was 
1 cell/mm3. Immunoelectrophoresis performed in CSF 
and serum indicated rupture of the blood–brain barrier. 
Antibiotherapy with ceftriaxone, amoxicillin, and acyclovir 
was introduced 2 days after admission and continued for 2 
weeks. CSF culture remained sterile at day 5. 
Several infectious causes for neurologic symptoms and 
acute hepatitis were excluded by nucleic acid and serologic 
assays performed on serum and CSF (online Appendix 
Table, www.cdc.gov/EID/content/17/8/102028-appT.htm). 
In contrast, HEV infection was diagnosed by detection of 
anti-HEV immunoglobulin (Ig) M (cutoff optical density 
ratio >10; threshold value 1 [Adaltis, Rome, Italy]) and 
by detection of HEV RNA in serum (5). Concurrently, 
anti-HEV IgM (Assure, MP Diagnostics, Illkirch, France) 
and HEV RNA were detected in CSF. HEV RNA levels 
measured by real-time PCR were ≈2 log greater in the 
serum (cycle threshold [Ct] 27) than in CSF (Ct 33). HEV 
RNA open reading frame 2 sequences were recovered 
from serum (GenBank accession nos. HQ702487 and 
HQ702490) and CSF (GenBank accession no. HQ702488) 
by using in-house protocols (14); they showed 100% nt 
identity with each other. Phylogenetic analysis identifi ed 
genotype 3, which is commonly found in autochthonous 
cases in France (4,5). No source for HEV transmission was 
identifi ed, including eating undercooked pork or drinking 
unsafe water; the patient had returned from Greece 3 weeks 
before her hospitalization. She recovered fully within 2 
weeks after onset of hepatitis and neurologic disorders. 
Liver parameters returned to within normal limits within 2 
weeks, and HEV RNA was cleared in serum after 3 weeks.
Case 2 occurred in a 49-year-old man hospitalized 
in July 2010 for acute proximal sensorimotor weakness 
of the limbs. Clinical examination showed proximal 
muscle weakness associated with paresthesia and pain 
of upper and lower limbs. Muscle stretch refl exes were 
diminished in the lower limbs. No pyramidal signs were 
evident. Nerve conduction study results were normal, and 
needle electromyography showed abnormal spontaneous 
activity and neurogenic recruitment in weak muscles. The 
diagnosis of acute infl ammatory polyradiculoneuropathy 
was retained. Liver enzymes were elevated: alanine 
aminotransferase 78 IU/L (reference <60 IU/L) and 
γ-glutamyl transferase 81 IU/L (reference <60 IU/L); 
bilirubin levels were within reference range. CSF was 
macroscopically clear; protein and glucose levels were 
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1.02 g/L (reference 0.15–0.45 g/L) and 3.6 mmol/L 
(reference 2.2–3.9 mmol/L), respectively. Leukocyte count 
was 10 cells/mm3, including 87% lymphocytes; erythrocyte 
count was 3 cells/mm3. CSF culture was sterile after 5 days. 
As in case 1, several infectious etiologies were excluded 
(online Appendix Table). Anti-HEV IgM was detected 
in serum (optical density ratio >10) but not in CSF. HEV 
RNA was detected by real-time PCR only in serum (Ct 
34). HEV RNA was of genotype 3 (GenBank accession 
no. HQ702489); nucleotide identity with sequences from 
case 1 was 91.5%. No source for HEV transmission was 
identifi ed, and the patient had not traveled abroad. Clinical 
outcome spontaneously improved within 2 weeks. HEV 
RNA test results 2 months postadmission were negative.
Conclusions
In these 2 cases, the temporal association between 
acute hepatitis and neurologic signs and symptoms, 
atypical neurologic features, and exclusion of a large panel 
of other potential etiologies are incentive to consider HEV 
as a possible cause of meningitis, diffuse neuralgic pain, 
and polyradiculoneuropathy. The association of neurologic 
signs and symptoms with acute hepatitis E was previously 
reported for several patients (online Appendix Table). 
Eight case-patients had Guillain-Barré syndrome (GBS) 
(3,4,6–11), which has been associated with a variety of 
bacterial or viral infections, including hepatitis viruses 
other than HEV (10,11,15). Four other reports described 
distinct clinical presentations of acute meningoencephalitis 
with seizure (1), Bell palsy (2), acute transverse myelitis 
(12), and neuralgic amyotrophy (13).
In most cases, only a few potential etiologies for GBS 
were tested for. In addition, in all but 2 reported cases (3,4), 
HEV diagnosis was based only on detection of anti-HEV 
IgM in serum. Dalton et al. detected HEV genotype 3 RNA 
in serum from a patient with acute hepatitis E in association 
with GBS, whereas HEV RNA testing of CSF was negative 
(3). Kamar et al. described polyradiculoneuropathy with 
central nervous system involvement in a kidney transplant 
recipient who had chronic hepatitis E 33 months after acute 
hepatitis E (4). In this case, HEV RNA was sequenced 
concurrently in serum and CSF at hospitalization for 
neurologic involvement. By contrast, the 2 cases in our 
report occurred concomitantly with acute hepatitis E. In the 
patient reported by Kamar et al. and in case-patient 1 in 
this report, HEV RNA load was ≈2 log lower in CSF than 
in serum (4). Rupture of the blood–brain barrier could have 
enabled passive entry of the virus into CSF. The negativity 
of HEV RNA testing in the CSF in case-patient 2 might 
be explained by lower titers in CSF than in serum because 
HEV RNA titer in serum was low. In the case reported 
by Kamar et al., phylogenetic analysis suggested that 
neurologic symptoms could be associated with emergence 
of neurotropic variants because clonal HEV RNA in CSF 
clustered apart from those found in serum. In case-patient 
1 reported here, HEV sequences recovered from serum 
and CSF were 100% identical; nevertheless, they were 
compared on a short open reading frame 2 fragment (106 
nt) and on samples collected at time of acute hepatitis E, 
whereas comparison was performed 33 months postacute 
hepatitis in the case reported by Kamar et al. Regarding 
the outcome of neurologic symptoms associated with 
acute hepatitis E, patients fully recovered within 1 and 
24 weeks, except in the cases reported by Chalupa et al. 
(10) and Kamar et al. (4). In this latter case-patient, no 
improvement was noted after 4 months, and the patient 
died of decompensated cirrhosis.
Previous and current observations suggest that HEV 
diagnostic testing should be performed for patients who 
have concurrent neurologic symptoms and liver cytolysis. 
Further investigations are needed to assess the actual 
prevalence of HEV infections in cases of neurologic 
disorders, especially those of unknown etiology.
Addendum
Kamar et al. recently reported neurologic complications 
in 7 (5.5%) patients among 126 with locally acquired 
acute and chronic HEV genotype 3 infection diagnosed 
during 2004–2009 at 2 hospitals in the United Kingdom 
and France (Kamar N, Bendall RP, Peron JM, Cintas P, 
Prudhomme L, Mansuy JM, et al. Hepatitis E virus and 
neurologic disorders. Emerg Infect Dis. 2011;17:173–9).
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